摘要
世界卫生组织于2022年10月制定了首份真菌重点病原清单,旨在加强全球对真菌感染和抗真菌药物耐药性的响应,关注并推动进一步的研究和政策干预。该真菌重点病原清单及其制定过程对于我国病原真菌及侵袭性真菌病(IFD)工作具有新的重要的启示作用:应加强我国IFD的公共卫生干预措施;进一步提高我国IFD及病原真菌的实验室检测与临床监管能力;有针对性地增加投资与支持以用于IFD诊疗和防控的创新性研发。
The WHO established the first fungal priority pathogens list(FPPL)in October 2022 to focus on and promote further research and policy interventions to strengthen the global response to fungal infections and antifungal resistance.The FPPL and its formulation process provide new significant insights for managing pathogenic fungi and invasive fungal disease(IFD)in China,necessitating the following key actions:Strengthen public health interventions for IFD.Further,it improves the ability of laboratory testing and clinical supervision for IFD and pathogenic fungi.Increase targeted investment and support for innovative research and development in IFD diagnosis,treatment,and prevention.
作者
刘伟
李若瑜
Liu Wei;Li Ruoyu(Department of Dermatology,Peking University First Hospital/National Clinical Research Center for Skin and Immune Diseases/Research Center for Medical Mycology,Peking University/Beijing Key Laboratory of Molecular Diagnosis on Dermatoses/Peking University First Hospital-National Institute for Communicable Disease Control and Prevention Joint Laboratory of Pathogenic Fungi,Beijing 100034,China)
出处
《中华流行病学杂志》
CAS
CSCD
北大核心
2023年第12期1984-1987,共4页
Chinese Journal of Epidemiology
基金
国家重点研发计划(2021YFC2300400,2021YFC2302005)
国家自然科学基金(81971912)
北京市自然科学基金(7232178)。
